Rethinking Bearish Outlook SoundHound: A Long-Term View
I used to be skeptical about SoundHound AI, but new developments and strategic moves are making me reconsider. This a...
An easy reference to world market indices names, with notes on regional coverage and how to recognize key benchmarks in discussions.
28,329 articlesI used to be skeptical about SoundHound AI, but new developments and strategic moves are making me reconsider. This a...
Volatility tests reshape the defensive playbook in consumer staples. Coca-Cola edges ahead of PepsiCo on cash flow an...
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
A $2.2 million dividend portfolio is quietly generating $13,200 a month in cash flow while avoiding complex K-1 taxes...
Snowflake posts strong growth while Palantir falters amid sticky macro. Investors shift toward data platforms as the ...
Apple is reportedly exploring a memory supplier in China to ease a chip shortage. Industry skeptics say the pivot won...
Biotech investors chase game-changing tech, but CRISPR Therapeutics carries real regulatory milestones and execution ...
A tough week tested my discipline as markets swung wildly. I trimmed a few positions and redirected cash to stronger ...
Intel has surged ahead in 2026, outpacing AMD by more than double in year-to-date gains. The rally prompts investors ...
Battery-focused BATT has surged past the SPY, led by a year of strong gains in battery metals and EV supply chains.
As July opens, a low-cost dividend ETF stands out for a $2,000 allocation. This report breaks down why it’s considere...
When a prominent investor trims a large stake, the market often swings. This piece breaks down what happened with Aca...